CD158a/g/h anticorps

N° du produit ABIN2749197

Il existe 1 publication pour ce produit. L’anticorps anti-CD158a/g/h Monoclonal Souris est utilisé pour la détection de CD158a/g/h dans des échantillons de Humain. Il a été validé pour FACS et IP.

Aperçu rapide pour CD158a/g/h anticorps (ABIN2749197)

Antigène: CD158a/g/h

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Flow Cytometry (FACS), Immunoprecipitation (IP)

Clone: HP-MA4

Détail du produit

Fonction: Anti-Hu CD158agh Purified

Réactivité croisée (Details): Human

Attributs du produit: The mouse monoclonal antibody HP-MA4 recognizes an extracellular epitope of CD158 isoforms KIR2DL1 (CD158a), KIR2DS5 (CD158g), KIR2DS1 (CD158h), and KIR2DS3. It does not recognize the isoforms CD158b1,d,f,i,j.

Purification: Purified by protein-A affinity chromatography.

Pureté: > 95 % (by SDS-PAGE)

Immunogène: Human NK cell line LB2

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Flow cytometry: Recommended dilution: 1-4 μg/mL.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Do not freeze

Stock: 4 °C

Stockage commentaire: Store at 2-8°C. Do not freeze.

Référence

Wiernik, Foley, Zhang, Verneris, Warlick, Gleason, Ross, Luo, Weisdorf, Walcheck, Vallera, Miller: "Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 14, pp. 3844-55, (2013) (PubMed).

Détail du antigène

Antigène: CD158a/g/h

Autre désignation: CD158agh

Sujet: Killer cell immunoglobulin like receptor, two Ig d,Killer cell immunoglobulin-like receptors (KIRs) are polymorphic transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. They are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain (such as CD158a / KIR2DL1) transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain (such as CD158g / KIR2DS5, CD158h / KIR2DS1, or KIR2DS3) lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for CD158 isoforms are subsets of MHC class I molecules.,KIR2DL1, NKAT, KIR2DS1, KIR2DS3, NKAT7, KIR2DS5, NKAT9, CD158g, CD158h, CD158a

ID gène: 3805

UniProt: Q99706